上市公司数据是反映行业发展情况的重要指标。本文从25家医药流通行业上市公司公开披露的2018年年报资料中,分析上市公司收入增长、盈利水平、费用控制、资本运作和战略实施的情况,从而反映一些行业未来变迁的新趋势。
<<The data of listed companies are an important indicator of the development of the industry. According to data in 2018 annual reports of 25 listed companies in the medicine distribution industry,it analyzes their performance in revenue growth,profitability,expense control,capital operation and strategy implementation in a bid to find some new trends along with the development of the industry.
<<